Activities of β-lactams, fluoroquinolones, amikacin and fosfomycin alone and in combination against Pseudomonas aeruginosa isolated from complicated urinary tract infections-Reference-Cited by-同舟云学术

Activities of β-lactams, fluoroquinolones, amikacin and fosfomycin alone and in combination against Pseudomonas aeruginosa isolated from complicated urinary tract infections

Published:1999 Issue:3 Volume:5 Page:130-138
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Hayami Hiroshi,Goto Toshihiro,Kawahara Motoshi,Ohi Yoshitada

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Link

http://www.springerlink.com/index/pdf/10.1007/s101560050022

Reference25 articles.

1. Trends in bacterial resistance to fluoroquinolones;Acar;Clin Infect Dis,1997

2. The crisis in antibiotic resistance;Neu;Science,1991

3. Carbapenem-hydrolyzing beta-lactamases

4. Multifocal outbreaks of metallo-β-lactamaseproducing Pseudononas aeruginosa resistant to broad-spectrum β- lactams, including carbapenems;Senda;Antimicrob Agents Chemother,1996

5. The role of fundamental research and biotechnology in finding solutions to the global problem of antibiotic resistance;Hancock;Clin Infect Dis,1997

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro and In Vivo Effect of Amikacin and Imipenem Combinations against Multidrug-Resistant E. coli;Tropical Medicine and Infectious Disease;2022-10-02

2. Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa;Antibiotics;2021-11-22

3. Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies;Antibiotics;2020-08-10

4. Actividad sinérgica y eficacia clínica de la asociación fosfomicina-ciprofloxacino en el tratamiento de una infección de malla quirúrgica con absceso de partes blandas por Enterobacter cloacae productor de carbapenemasa;Enfermedades Infecciosas y Microbiología Clínica;2017-02

5. Synergistic activity and clinical efficacy of fosfomycin and ciprofloxacin combination treatment for soft tissue infection caused by carbapenemase-producing Enterobacter cloacae;Enfermedades infecciosas y microbiologia clinica (English ed.);2017-02